Loss of BMP7 results in brown fat hypoplasia and reduced UCP1 levels [158], whereas systemic BMP7 administration increases BAT mass and thermogenic capacity, highlighting its therapeutic potential in obesity [159]. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.